NCT00470184 Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00463840 Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00462501 Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Status COMPLETED Phase NA
NCT00458809 Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00456599 Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00454636 A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. Status COMPLETED Phase PHASE2
NCT00453115 Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) Status UNKNOWN Phase PHASE2
NCT00452881 Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC Status UNKNOWN Phase PHASE2
NCT00452374 Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL Status COMPLETED Phase PHASE1/PHASE2
NCT00448838 Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase NA
NCT00448760 Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00448682 Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By Surgery Status TERMINATED Phase PHASE2
NCT00448552 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00447967 Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients Status COMPLETED Phase PHASE2
NCT00444678 Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00439426 A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. Status COMPLETED Phase PHASE2
NCT00438737 Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT00436800 Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE2
NCT00436241 A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. Status COMPLETED Phase PHASE2